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A B S T R A C T
Purpose: To examine the process for transitioning adolescents on dietary management for intractable
epilepsy to adult neurologic care.
Methods: Ten patients, ages 6–16 years when the ketogenic or modiﬁed Atkins diet was initiated, were
identiﬁed; age at transition was 18–43 years. All patients were seen at Johns Hopkins Hospital,
Baltimore, Maryland.
Results: Seven remain on diets (4 Ketogenic, 3 modiﬁed Atkins diet) at this time with mean diet duration
of 15.5 years (range 4–32 years). Most patients had excellent but not complete seizure control and
several had recurrence or worsening of seizures with attempts to wean dietary therapy, hence the need
to continue. Three main transition options were utilized: (1) continue being followed in pediatric clinic
(n = 2), (2) establish care with an adult neurologist (n = 2), or 3) receive care from the Adult Epilepsy Diet
Center (n = 6). Those patients followed in the Adult Epilepsy Diet Center were slightly more likely to
remain on dietary therapy following transition (5/6 vs. 1/4, p = 0.12).
Conclusion: It is important for adolescents with epilepsy receiving ketogenic diets to have transition
plans in place for when they become adults. Adult epilepsy diet centers are the ideal option when
possible.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Adolescents with chronic diseases require detailed transition
plans from pediatric to adult medical care, typically around 18
years of age.1,2 For patients with epilepsy, the complex issues
regarding driving, pregnancy, employment, and independence are
signiﬁcant and current recommendations are for pediatricians to
begin discussions regarding transitioning to adult clinics as early as
age 12 years.3–5 The American Academy of Pediatrics has recently
published formal recommendations for transitioning patients with
chronic conditions into adult clinics.1
The ketogenic diet (KD) is a high fat, low carbohydrate dietary
therapy for children with medication-refractory epilepsy.6 Most
children remain on the KD for up to 2 years, at which point it is
weaned to discontinuation. However, some will have recurrence orAbbreviations: KD, ketogenic diet; MAD, modiﬁed Atkins diet; AEDC, adult epilepsy
diet center.
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http://dx.doi.org/10.1016/j.seizure.2013.03.005worsening of seizures with weaning of the KD, requiring long-term
dietary management.7 To the best of our knowledge, there have not
been any recommendations for how best to manage patients who
continue to use the KD as they reach adulthood.
The modiﬁed Atkins diet (MAD) was ﬁrst described in 2003 as a
less restrictive version of the KD.8 Patients do not calculate protein,
calories, or ﬂuids and restrict carbohydrate intake to 10 g per day
while eating signiﬁcant amounts of fat. The MAD has been
investigated for use in adults since its creation, primarily due to its
inherent ﬂexibility as compared to the KD.8–10 In August 2010,
Johns Hopkins Hospital opened an Adult Epilepsy Diet Center
(AEDC) with an adult epileptologist (MCC) and dietitian (BJH)
primarily responsible for dietary management of patients and
mostly using the MAD de novo with support, guidance, and
training from a pediatric epileptologist with expertise in dietary
therapies (EK).
This case series was designed to investigate epilepsy treatment
outcomes in patients who started either the KD or MAD as children
at Johns Hopkins and remained on diet therapy while transitioning
to adulthood. We hypothesized that our AEDC provided a useful
option for those patients requiring long-term, adult dietary
management.vier Ltd. All rights reserved.
Table 1
Patients who reached adulthood still receiving dietary therapy.








Transition option Seizure control
over baseline
at transition (%)
1 Female Mitochondrial complex 1, 3 6 18 20 KD (4:1) AEDC 90
2 Female JME 16 18 20 MAD AEDC 100
3 Male Mitochondrial complex 3 7 20 21 MAD AEDC 50
4 Male LGS 10 20 25 Off Adult neurologist 50
5 Male HIE 14 21 23 Off AEDC 50
6 Male HIE 6 23 25 Off Adult neurologist 50
7 Male Tuberous sclerosis 6 26 33 KD (3:1) AEDC 99
8 Male LGS 12 43 44 KD (4:1) AEDC 100
9 Female HIE 11 N/A (not transitioned) 26 KD (4:1) Continue with pediatrics 90
10 Female None (idiopathic partial) 15 N/A (not transitioned) 30 Off Continue with pediatrics 50
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Medical records since 1994 were reviewed for all adults with
epilepsy treated with the KD or MAD at Johns Hopkins Hospital
who were actively receiving dietary therapy at the time they
turned 18 years of age. All adult patients were seen in either the
pediatric ketogenic diet center, AEDC, or with a different adult
neurologist for their clinic visits. Patients treated with the KD as
children were part of an ongoing study of the effectiveness of the
ketogenic diet, one patient participated in a study of the MAD,11
and all adults seen in the AEDC consented to be part of an ongoing
study of dietary therapy for adults. Categorical data were analyzed
using a Fisher’s exact test (P = 0.05). All studies were approved by
the Johns Hopkins Committee on Clinical Investigation.
3. Results
Ten patients were identiﬁed, current ages 20–44 years (Table 1).
All started dietary therapy as children or adolescents (mean age
10.3 years, range 6–16 years), with all but one (Patient 2) initially
starting with the classic KD. Etiologies varied and included hypoxic
ischemic encephalopathy (3), Lennox Gastaut Syndrome (2),
mitochondrial disorders (2), juvenile myoclonic epilepsy (1),
tuberous sclerosis complex (1), and idiopathic partial epilepsy (1).
Patients in this study had somewhat prolonged use of dietary
management; mean 15.5 years (range, 4–32 years). There were
multiple reasons why these adults continued dietary treatment of
their epilepsy. Eight achieved good seizure control with the KD
(50–99% seizure reduction compared to before the KD was started).
Two patients (Patients 2 and 8) were seizure-free for years after
several anticonvulsants failed to control their seizures. At one time
during treatment, four had either attempted to reduce the KD ratio,
completely wean the KD, or exceed the recommended carbohy-
drate intake on the MAD with resultant immediate worsening of
seizures.
Eight patients had moderate to severe developmental delay and
were dependent on parent or sibling caregivers for food prepara-
tion. All of these care providers reported no concerns about
compliance or difﬁculty administering the KD or MAD. Two
patients were of normal intelligence or had mild developmental
delay (Patients 2 and 10). Two patients (Patients 1 and 5) received
liquid ketogenic diet formulas through gastrostomy tubes and
therefore compliance was not an issue. This is similar to the 20% of
children in our pediatric ketogenic diet center on formula only at
this time.
Eight adolescents were transitioned to adult clinics. The mean
age at transfer to adult clinic was 23.6 years, with the two oldest
presenting to AEDC at ages 26 and 43 years following several years
of self-management.12 Four adults were switched from the KD to
the MAD for convenience, without any resultant seizure increase.All patients remain on anticonvulsants (mean 2.4 anticonvulsants;
range, 1–4), most commonly levetiracetam (7) and clonazepam (3).
Three major categories of transition options were identiﬁed as
used by young adults with epilepsy on dietary therapy. First, the
most common, was a transition to the Johns Hopkins AEDC. Six
adults were seen in this clinic; three had sporadic care by private
dietitians or self-management then chose to be followed in the
AEDC for more formal management, two had been followed for 7
and 8 years in the pediatric ketogenic diet center at Johns Hopkins
and were then referred, and one was an 18 year old with juvenile
myoclonic epilepsy enrolled in a MAD study since age 16 years.11
The second option identiﬁed was to transfer care to an adult
neurologist who was not a member of a ketogenic diet team. This
was utilized by two patients (Patients 4 and 6), and both
discontinued diets (KD and MAD respectively) within two years
of the transfer of care. Both were developmentally disabled
individuals with parents who continued the exact same dietary
regimen without dietitian involvement, then gradually discon-
tinued it without complications.
The third option was to continue care through a pediatric
ketogenic diet center. Two adults had local adult neurologists
available for emergencies and returned to Baltimore every 2–3
years for care. One patient’s mother (Patient 10) emailed one year
ago indicating she had discontinued her daughter’s KD after 14
years total duration, without worsening seizures. Another (Patient
9) continues to return for care for now.
At this time, six remain on dietary treatment (4 on KD, 2 on
MAD). A greater percentage of patients who transitioned to the
AEDC instead of selecting another alternative remain on dietary
therapy at the current time, although this difference did not reach
statistical signiﬁcance because of the relatively small sample size
(5 of 6 (83%) vs. 1 of 4 (25%), P = 0.12). The ﬁve adults still followed
in our AEDC are all local to Maryland and surrounding states.
4. Discussion
As adolescents with intractable epilepsy approach adulthood, it
is critical to have a thorough plan in place for transition of their
medical care.3–5 For the majority of adults with epilepsy,
anticonvulsant management is not vastly different between
pediatric and adult providers. However, dietary therapy is
potentially more complicated to continue as an adult because it
requires a trained adult neurologist familiar with either the KD or
MAD, and an adult dietitian as well.9 Although pediatric ketogenic
diet teams can continue to provide care, intermittent hospitaliza-
tions to adult units and issues such as pregnancy, living
independently, and different nutritional requirements make this
potentially problematic for adults. At Johns Hopkins Hospital,
although no upper age limit requirement for transition exists; most
patients are transitioned to adult providers by age 21 years.
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for continuing to provide appropriate care of pediatric patients
receiving dietary epilepsy management when they reach adult-
hood. Individual hospitals and pediatric neurology clinics can
make their own personal decisions on how best to handle
transitioning these patients, however, we believe that having an
AEDC is ideal for several reasons. The AEDC team was interested in
seeing new patients, motivated to keep them on dietary therapy,
and in frequent communication with both the referring internists
and pediatric ketogenic diet teams. We have found that having the
AEDC in the same location as the pediatric ketogenic diet center
allows for close communication between neurologists and a
smoother transition process. Additionally, for the adults who were
being ‘‘self-managed’’, the AEDC became a medical ‘‘home’’ for
managing potential side effects, providing menu variety, and
communicating with local primary care providers that had not
previously existed.
Future directions include ﬁnding ways to improve the
transition process even further. Several studies have proposed
the concept of a ‘‘transition clinic’’ with both pediatric and adult
neurologists present during a clinic visit.4,5 This strategy was
successfully utilized during several clinics at the AEDC, and could
be implemented as well as having both pediatric and adult
dietitians together to discuss the diet transition plan. Most of these
10 patients were local to Maryland, so there may be some value in
providing dietary management services via email or video
teleconferencing as another transition plan, with a local adult
neurologist in charge of the majority of care.
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